Daniel O'Connell Md,Phd

Daniel O'Connell Md,Phd Email and Phone Number

Partner @ Novo Holdings
San Francisco, CA, US
Daniel O'Connell Md,Phd's Location
San Francisco, California, United States, United States
Daniel O'Connell Md,Phd's Contact Details
About Daniel O'Connell Md,Phd

Investor focused on the healthcare space experienced at evaluating novel opportunities across a spectrum of indications and stages of development. Strong analytical skills with special focus on distilling the most salient information into actionable items. Especially skilled at evaluating preclinical data, clinical data, drug development plans, and regulatory strategies, and translating highly technical information into accessible messages across a variety of audiences including clinicians, scientists, generalist investors, and the lay person. Strong passion for novel mechanisms that treat areas of unmet medical need.

Daniel O'Connell Md,Phd's Current Company Details
Novo Holdings

Novo Holdings

View
Partner
San Francisco, CA, US
Daniel O'Connell Md,Phd Work Experience Details
  • Novo Holdings
    Partner
    Novo Holdings
    San Francisco, Ca, Us
  • Kivu Bioscience
    Board Chair
    Kivu Bioscience Sep 2024 - Present
    San Francisco, Ca, Us
  • Terremoto Biosciences
    Board Member
    Terremoto Biosciences Nov 2023 - Present
    South San Francisco, California, Us
  • Novo Holdings
    Partner
    Novo Holdings Jun 2022 - Present
    Hellerup, Gentofte, Dk
  • Link Immunotherapeutics
    Board Member
    Link Immunotherapeutics Mar 2021 - Oct 2023
    Seattle, Washington, Us
  • Bristol Myers Squibb
    Executive Director, Equity And Venture Capital
    Bristol Myers Squibb Apr 2020 - Jun 2022
    Lawrence Township, Nj, Us
    Leading a team focused on therapeutic opportunities for M&A, equity investments, partnerships, in-licensing, clinical collaborations, and other strategic transactions.
  • Logicbio Therapeutics
    Board Member
    Logicbio Therapeutics Jun 2017 - Dec 2020
    Lexington, Massachusetts, Us
    LogicBio Therapeutics is a gene-therapy company with a mission to develop cures for early-onset life-threatening diseases. The company’s GeneRide technology hitches a therapeutic transgene to a native promoter without disrupting its normal function in the host genome, enabling permanent expression of a functional version of a missing or faulty gene. Thus − with just a single treatment early in a child’s life – LogicBio can potentially deliver a life-long cure for a devastating disease.
  • Arix Bioscience Plc
    Investment Director
    Arix Bioscience Plc Oct 2016 - Jul 2019
    Arix Bioscience is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks needed to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors
  • Precithera
    Board Member
    Precithera Jul 2017 - Jun 2019
    PreciThera, Inc. is a biotechnology company committed to the development of therapies for rare bone diseases using the combined application of computational technology and a deep understanding of disease pathology. The company focuses on heterogeneous genetic disorders that primarily manifest in bone dysfunction. In depth understanding of disease mechanism will allow PreciThera’s targeted strategies to meaningfully impact both the skeletal symptoms as well as the extraskeletal issues found in these patients.
  • Harpoon Therapeutics
    Board Observer
    Harpoon Therapeutics Jun 2017 - Feb 2019
    South San Francisco, California, Us
    Harpoon Therapeutics is an immuno-oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases. The company is developing a broad portfolio of drug candidates, and plans to develop its own oncology products in the U.S., as well as selectively partner other products to access global markets. Additionally, Harpoon will seek strategic partnerships to expand its proprietary and platform technologies for use in oncology and other diseases.
  • Orbimed Advisors
    Private Equity
    Orbimed Advisors May 2012 - Aug 2016
    New York, Ny, Us
    Clinical diligence, scientific diligence, capital structure, forecasting and modeling, financial analysis
  • Tufts University
    Medical Student
    Tufts University Aug 2010 - May 2012
    Medford, Massachusetts, Us
    Completion of medical school clinical rotations, including surgery, medicine, ob/gyn, and psychiatry.
  • The Princeton Review
    Premiere Tutor, Mcat
    The Princeton Review 2003 - 2011
    New York, Ny, Us
    I teach classes and provide one-on-one tutoring for students preparing to take the MCAT for admission to medical school. My personal experience with organic chemistry provides me real world knowledge and examples that I use in the classroom to further students' understanding of fundamental concepts.
  • Arisaph Pharmaceuticals
    Associate Director, Cardiovascular Research
    Arisaph Pharmaceuticals Sep 2007 - Aug 2010
    Arisaph is interested in developing novel small molecule therapeutics for the treatment of diabetes, cancer, and cardiovascular disease. Our CV research focuses in particular on pathways that regulate levels of HDL cholesterol, with the ultimate goal of using innovative strategies in chemistry, biochemistry, and pharmacology to lower the risk of heart disease.
  • Wyeth
    Intern, Medicinal Chemistry
    Wyeth Jun 2002 - Sep 2002
    New York, New York, Us
    Organic synthesis, NMR, MS

Daniel O'Connell Md,Phd Skills

Biochemistry Biotechnology Cancer Pharmaceutical Industry Organic Synthesis Molecular Biology Life Sciences Chemistry Pharmacology Clinical Research Drug Discovery Medicine Organic Chemistry Cell Culture Medicinal Chemistry Protein Chemistry Protein Purification Lifesciences Cell Biology Hplc

Daniel O'Connell Md,Phd Education Details

  • Tufts University School Of Medicine
    Tufts University School Of Medicine
    Organic Chemistry
  • Massachusetts Institute Of Technology
    Massachusetts Institute Of Technology
    Chemistry
  • Suncoast High School
    Suncoast High School

Frequently Asked Questions about Daniel O'Connell Md,Phd

What company does Daniel O'Connell Md,Phd work for?

Daniel O'Connell Md,Phd works for Novo Holdings

What is Daniel O'Connell Md,Phd's role at the current company?

Daniel O'Connell Md,Phd's current role is Partner.

What is Daniel O'Connell Md,Phd's email address?

Daniel O'Connell Md,Phd's email address is da****@****bms.com

What is Daniel O'Connell Md,Phd's direct phone number?

Daniel O'Connell Md,Phd's direct phone number is +121273*****

What schools did Daniel O'Connell Md,Phd attend?

Daniel O'Connell Md,Phd attended Tufts University School Of Medicine, Massachusetts Institute Of Technology, Suncoast High School.

What skills is Daniel O'Connell Md,Phd known for?

Daniel O'Connell Md,Phd has skills like Biochemistry, Biotechnology, Cancer, Pharmaceutical Industry, Organic Synthesis, Molecular Biology, Life Sciences, Chemistry, Pharmacology, Clinical Research, Drug Discovery, Medicine.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.